A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2011
10/26/2011	CN101306166B Traditional Chinese medicine orally taken for treating chronic nasal sinusitis
10/26/2011	CN101301446B Oral Chinese medicine for treating cough due to pathogenic wind-cold
10/25/2011	US8044182 Adiponectin and uses thereof
10/25/2011	US8044102 administering to animals antibiotic deriavtives such as florfenicol or flunixin meglumine, for prevention of urogenital, respiratory system and gastrointestinal disorders, vision defects and mastitis; veterinary medicine
10/25/2011	US8044056 Adenine compound
10/25/2011	US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/25/2011	US8044018 Reagents and methods for smooth muscle therapies
10/25/2011	US8043855 vector contains an adenoviral genome from which the open reading frames E1 and/or E3 have been deleted, but retains enough sequence to make it able to replicate in vitro; also contains a DNA sequence regulated by promoters that encode for fibrosis treatment proteins
10/25/2011	US8043624 Compositions and methods for treatment of microbial infections
10/20/2011	WO2011130605A2 Compositions and methods for treating pulmonary hypertension
10/20/2011	WO2011130552A2 Serca2 therapeutic compositions and methods of use
10/20/2011	WO2011127538A1 Compound for treatment of respiratory condition or disease
10/20/2011	WO2011093815A3 Pharmaceutical compositions comprising formoterol and mometasone
10/20/2011	WO2011034896A3 Small molecule inhibitors of the alpha4-paxillin interaction
10/20/2011	US20110257271 Derivatives of dimethylcurcumin
10/20/2011	US20110257232 Biphenyl oxadiazole derivatives as sphingosine-1-phosphate receptors modulators
10/20/2011	US20110257223 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
10/20/2011	US20110257222 Compounds and methods for the treatment of pain and other diseases
10/20/2011	US20110257215 Novel co-crystal of tiotropium bromide
10/20/2011	US20110257208 Compounds useful as faah modulators and uses thereof
10/20/2011	US20110257198 Piperidine derivatives useful as orexin antagonists
10/20/2011	US20110257192 Compound for treatment of respiratory condition or disease
10/20/2011	US20110257188 Compositions and methods for the treatment of nasal conditions
10/20/2011	US20110257177 Benzylthiotetrazole inhibitors of store operated calcium release
10/20/2011	US20110257171 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors
10/20/2011	US20110257161 Novel diaza-bicyclononyl-phenyl derivatives and their medical use
10/20/2011	US20110257153 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
10/20/2011	US20110257138 Monoterpenes for treating respiratory tract diseases, in particular bronchopulmonary diseases
10/20/2011	US20110257137 Heterocyclic inhibitors of histamine receptors for the treatment of disease
10/20/2011	US20110257127 A2b adenosine receptor antagonists
10/20/2011	US20110257077 Compounds and compositions as channel activating protease inhibitors
10/20/2011	US20110256245 Methods and compositions of cannabis extracts
10/20/2011	US20110256220 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
10/20/2011	US20110256151 Antibodies to human il-1beta
10/20/2011	US20110256147 Diagnostic and treatment methods for cancer based on immune inhibitors
10/20/2011	US20110256130 Methods of treating inflammatory disorders
10/20/2011	US20110256126 IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof
10/20/2011	US20110256101 Serca2 therapeutic compositions and methods of use
10/20/2011	US20110256070 Pharmaceutical compositions and methods for administering the same
10/20/2011	US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof
10/20/2011	US20110253140 Formulations containing large-size carrier particles for dry powder inhalation aerosols
10/20/2011	US20110253135 Metal coordination complexes of volatile drugs
10/20/2011	US20110253133 Methods and compositions for administration of oxybutynin
10/20/2011	CA2796268A1 Methods for treatment of sleep-related breathing disorders
10/20/2011	CA2796207A1 Compound for treatment of respiratory condition or disease
10/20/2011	CA2796083A1 Compositions and methods for treating copd exacerbation
10/19/2011	EP2377851A1 Isoquinoline derivative
10/19/2011	EP2377850A1 TRPV1 vanilloid receptor antagonists with a bicyclic portion
10/19/2011	EP2377537A1 Pirfenidone therapy and inducers of cytochrome P450
10/19/2011	EP2376489A1 Alkaloid aminoester derivatives and medicinal composition thereof
10/19/2011	EP2376462A1 Thiazoles as cannabinoid receptor ligands
10/19/2011	EP2376430A2 New activators for treating and/or preventing diseases or medical conditions which benefit from an increased transport of hyaluronan across a lipid bilayer
10/19/2011	EP2376429A2 Compounds having activity in correcting mutant cftr cellular processing
10/19/2011	EP2376428A2 New inhibitors for treating diseases associated with an excess transport of hyaluronan
10/19/2011	EP2375912A1 Compositions and methods for the treatment of throat discomfort
10/19/2011	EP1957451B1 Soft anticholinergic zwitterions
10/19/2011	EP1948596B1 Soft anticholinergic esters
10/19/2011	EP1937250B1 Ligustilide derivatives for the treatment of inflammatory disorders
10/19/2011	EP1896473B1 1-[[2-amino-3-(substituted alkyl)-3h-benzimidazolyl]methyl]-3-subtituted-1,3-dihydro-benzoimidazol-2-ones as inhibitors of respiratory syncytial virus replication
10/19/2011	EP1762610B1 Truncated dance, dance complex and method of using these
10/19/2011	EP1499613B1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/19/2011	EP1494671B1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists
10/19/2011	EP1482931B1 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/19/2011	EP1372735B1 Conjugate of hydroxyalkyl starch and an active agent
10/19/2011	EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/19/2011	CN1977907B Eriobotuya japonica extract, and composition containing same and use
10/19/2011	CN1706385B New composition for treating seasonal and perennial allergic rhinitis
10/19/2011	CN102224143A 1h-benz imidazole-5-carboxamides as anti-inflammatory agents
10/19/2011	CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/19/2011	CN102224141A Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
10/19/2011	CN102223884A Solid pharmaceutical composition
10/19/2011	CN102223876A Nanoemulsion therapeutic compositions and methods of using the same
10/19/2011	CN102220263A Mycoplasma bovis attenuated strain and application thereof
10/19/2011	CN102219748A Amorphous Ambrisentan and preparation method thereof
10/19/2011	CN102219686A Caffeoyl derivative and use of coffeeoyl derivative in preparing drugs against respiratory syncytial viruses
10/19/2011	CN102218144A Method for regulating content of micro-ribonucleic acids in organism and use thereof
10/19/2011	CN102218132A Medicinal composition for treating nasal bleeding
10/19/2011	CN102218095A Processing method of myrobalan-processed kusnezoff monkshood root as mongolian medicine
10/19/2011	CN102218085A Quality control method for leaves of lithocarpus litseifolius(Hance)Chun as medicinal material
10/19/2011	CN102218075A Composition for down-regulating pro-inflammatory markers
10/19/2011	CN102218058A Application of sparstolenin B as TLR2 (Toll-like receptor 2)/TLR4 (Toll-like receptor 4) antagonist in pharmacy
10/19/2011	CN102218041A Ebastine solid dispersion and high-dissolubility ebastine tablet prepared by the same
10/19/2011	CN102218038A Formula, preparation method and application of tolazoline hydrochloride liposome combination medicine
10/19/2011	CN102217797A Chinese medicinal health-care cigarette
10/19/2011	CN102217757A Plant superoxide dismutase buccal tablets and preparation method thereof
10/19/2011	CN102217712A Pinene-containing feed or feed additive
10/19/2011	CN101985020B Chinese medicament for treating tracheitis
10/19/2011	CN101874880B Method for preparing traditional Chinese medicine for treating pediatric wind-heat lung obstruction type pneumonia asthma
10/19/2011	CN101773601B Throat-care granules in bag for treatment of pharyngitis
10/19/2011	CN101757015B Composite of breviscapinum and panax notoginseng saponins Rg1 for treating pulmonary fibrosis and application thereof
10/19/2011	CN101703469B Preparation method and products of danofloxacin mesylate liposome
10/19/2011	CN101696205B 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition
10/19/2011	CN101474150B Stable alprostadil injection emulsion and preparation method thereof
10/19/2011	CN101406611B Chinese medicine preparation for treating bronchial asthma
10/19/2011	CN101167749B Preparing method for improving toad venom taste
10/19/2011	CN101104074B Orally taken traditional Chinese medicine for treating cold syndrome type asthma in children
10/19/2011	CN101104053B Decoction medicine for treating liver qi stagnancy type pharyngitis and preparation method
10/19/2011	CN101104032B Decoction medicine for treating damp-heat type pharyngitis and preparation method
10/19/2011	CN101104025B Decoction medicine for treating cough caused by long-lasting diseases and preparation method
10/19/2011	CN101104021B Decoction medicine for treating blood-heat type pharyngitis and preparation method

1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 878